Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
13 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
65.4 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
12
12 articles ont été cités au moins 12fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Total citations reçues
651
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
51
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
16
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
CABINET DU DR Mohammed FAHIM
126 RUE SOMMEVILLE, 77380 COMBS LA VILLE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of the American College of Cardiology · 2016
Annals of emergency medicine · 2005
British journal of clinical pharmacology · 2014
AimsParaquat poisoning is a medical problem in many parts of Asia and the Pacific. The mortality rate is extremely high as there is no effective treatment. We analyzed data collected during an ongoing cohort study on self‐poisoning and from a randomized controlled trial assessing the efficacy of immunosuppressive therapy in hospitalized paraquat‐intoxicated patients. The aim of this analysis was to characterize the toxicokinetics and toxicodynamics of paraquat in this population.MethodsA non‐linear mixed effects approach was used to perform a toxicokinetic/toxicodynamic population analysis in a cohort of 78 patients.ResultsThe paraquat plasma concentrations were best fitted by a two compartment toxicokinetic structural model with first order absorption and first order elimination. Changes in renal function were used for the assessment of paraquat toxicodynamics. The estimates of toxicokinetic parameters for the apparent clearance, the apparent volume of distribution and elimination half‐life were 1.17 l h−1, 2.4 l kg−1 and 87 h, respectively. Renal function, namely creatinine clearance, was the most significant covariate to explain between patient variability in paraquat clearance.This model suggested that a reduction in paraquat clearance occurred within 24 to 48 h after poison ingestion, and afterwards the clearance was constant over time. The model estimated that a paraquat concentration of 429 μg l−1 caused 50% of maximum renal toxicity. The immunosuppressive therapy tested during this study was associated with only 8% improvement of renal function.ConclusionThe developed models may be useful as prognostic tools to predict patient outcome based on patient characteristics on admission and to assess drug effectiveness during antidote drug development.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
ClinicoEconomics and outcomes research : CEOR · 2026 · Journal Article
Hayes K, Fahim M, Hu FS, Panaccio MP, et al.
ACS omega · 2025 · Journal Article
Elaaraj I, Driouch M, Kadiri M, Safi Z, et al.
Rheumatology and therapy · 2021 · Journal Article
Hayes K, Panaccio MP, Goel N, Fahim M
Journal of the American College of Cardiology · 2016 · Journal Article
Keenan T, Zhao W, Rasheed A, Ho WK, et al.
Journal of pharmacy & bioallied sciences · 2015 · Journal Article
Fahim M, Singh M, Kamal YT, Mukhtar HM, et al.
British journal of clinical pharmacology · 2014 · Journal Article
Wunnapuk K, Mohammed F, Gawarammana I, Liu X, et al.
Annals of emergency medicine · 2005 · Journal Article
Roberts DM, Seneviratne R, Mohammed F, Patel R, et al.
Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2010 · Journal Article
Moffatt A, Mohammed F, Eddleston M, Azher S, et al.
Medicine · 2025 · Journal Article
Rahman HAU, Fahim MAA, Salman A, Ahmed SH, et al.
BMC emergency medicine · 2007 · Journal Article
Eddleston M, Juszczak E, Buckley NA, Senarathna L, et al.
Lupus · 2019 · Journal Article
Elkoumi MA, Emam AA, Allah MAN, Sherif AH, et al.
BMC nephrology · 2024 · Journal Article
Pett J, Linhart C, Osborne N, Morrell S, et al.
Open access rheumatology : research and reviews · 2021 · Journal Article
Hayes K, Panaccio MP, Houston P, Niewoehner J, et al.
CCDC 1904847: Experimental Crystal Structure Determination
Related Article: ES-SOUNNI, Bouchra, FAHIM, Mohammed, El Yazidi, Mohamed, Saadi, Mohamed, El Ammari, Lahcen Bouchra Es-Sounni, Mohamed El Yazidi, Mohamed Saadi , Lahcen El Ammari, Mohammed Fahim|2020|CSD Communication||
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
<strong>Article full text</strong><br>The article associated with this page has been accepted for online publication and is in the final stages of production. The pre-typeset version is available above.<br>The above summ
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
<strong>Article full text</strong><br>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
<strong>Article full text</strong><br>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
<strong>Article full text</strong><br>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
<strong>Article full text</strong><br>The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).